Deciphering the molecular pathway of an asiaticosiderich fraction of Centella asiatica as an anti-melanogenesis agent

Q3 Pharmacology, Toxicology and Pharmaceutics Journal of HerbMed Pharmacology Pub Date : 2024-04-01 DOI:10.34172/jhp.2024.49332
Agustina Setiawati, Brigitta Amanda Maharani, Putu Addelia Puspa Sari, K. A. Widyantara, B. Saputra, Rifki Febriansah, Rini Dwiastuti
{"title":"Deciphering the molecular pathway of an asiaticosiderich fraction of Centella asiatica as an anti-melanogenesis agent","authors":"Agustina Setiawati, Brigitta Amanda Maharani, Putu Addelia Puspa Sari, K. A. Widyantara, B. Saputra, Rifki Febriansah, Rini Dwiastuti","doi":"10.34172/jhp.2024.49332","DOIUrl":null,"url":null,"abstract":"Introduction: Melanin is a defense against UV radiation; however, it leads to significant cosmetic issues mainly melasma and hyperpigmentation. This study evaluated the potential effect of ethyl acetate (EtOAc) fraction of Centella asiatica extract in vitro inhibition activity against tyrosinase (TYR). Bioinformatics and in silico experiments were also employed to predict molecular pathways of asiaticoside, as the main active compound. Methods: Centella asiatica was extracted with ethanol and then fractionated with EtOAc. The fraction was tested in vitro for TYR inhibitory activity, and its active compounds were investigated using thin-layer chromatography (TLC). After obtaining the online database of the genes related to pigmentation and melanogenesis in the skin, the genes affected by asiaticoside were determined by the Venn diagram. The top 10 target proteins, underlying molecular pathways, got from CytoHubba, were further studied to figure out their molecular pathway. The molecular docking was conducted on two selected protein targets. Results: EtOAc fraction of C. asiatica extract demonstrated strong TYR inhibitory activity with an IC50 of 18.85 μg/mL. TLC profiling of the EtOAc fraction revealed the Rf value of 0.28 for the standard, Rf value of 0.26, 0.21, and 0.15 for the extract, and Rf value of 0.26 and 0.15 for the fraction. Asiaticoside inhibited melanogenesis by elaborating many molecular pathways involving keratinocytes, melanocytes, fibroblast, and endothelial cells by elaborating cytokine, growth factor, extracellular matrix, and melanin degradation enzyme Conclusion: Asiaticoside-rich C. asiatica fraction has the potential as an anti-melanogenesis agent through its TYR inhibitory activity and many molecular pathways.","PeriodicalId":15934,"journal":{"name":"Journal of HerbMed Pharmacology","volume":"24 7","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of HerbMed Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/jhp.2024.49332","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Melanin is a defense against UV radiation; however, it leads to significant cosmetic issues mainly melasma and hyperpigmentation. This study evaluated the potential effect of ethyl acetate (EtOAc) fraction of Centella asiatica extract in vitro inhibition activity against tyrosinase (TYR). Bioinformatics and in silico experiments were also employed to predict molecular pathways of asiaticoside, as the main active compound. Methods: Centella asiatica was extracted with ethanol and then fractionated with EtOAc. The fraction was tested in vitro for TYR inhibitory activity, and its active compounds were investigated using thin-layer chromatography (TLC). After obtaining the online database of the genes related to pigmentation and melanogenesis in the skin, the genes affected by asiaticoside were determined by the Venn diagram. The top 10 target proteins, underlying molecular pathways, got from CytoHubba, were further studied to figure out their molecular pathway. The molecular docking was conducted on two selected protein targets. Results: EtOAc fraction of C. asiatica extract demonstrated strong TYR inhibitory activity with an IC50 of 18.85 μg/mL. TLC profiling of the EtOAc fraction revealed the Rf value of 0.28 for the standard, Rf value of 0.26, 0.21, and 0.15 for the extract, and Rf value of 0.26 and 0.15 for the fraction. Asiaticoside inhibited melanogenesis by elaborating many molecular pathways involving keratinocytes, melanocytes, fibroblast, and endothelial cells by elaborating cytokine, growth factor, extracellular matrix, and melanin degradation enzyme Conclusion: Asiaticoside-rich C. asiatica fraction has the potential as an anti-melanogenesis agent through its TYR inhibitory activity and many molecular pathways.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
破译积雪草苷成分作为抗黑色素生成剂的分子途径
简介黑色素可抵御紫外线辐射,但也会导致严重的美容问题,主要是黄褐斑和色素沉着。本研究评估了积雪草提取物乙酸乙酯(EtOAc)馏分在体外抑制酪氨酸酶(TYR)活性的潜在作用。研究还采用了生物信息学和硅学实验来预测作为主要活性化合物的积雪草苷的分子途径。研究方法用乙醇提取积雪草,然后用乙酸乙酯分馏。对馏分进行体外 TYR 抑制活性测试,并使用薄层色谱法(TLC)研究其活性化合物。在获得皮肤色素沉着和黑色素生成相关基因的在线数据库后,通过维恩图确定了受asiaticoside影响的基因。从 CytoHubba 中获得的前 10 个靶蛋白及其分子通路被进一步研究,以找出其分子通路。对选定的两个靶蛋白进行了分子对接。研究结果茜草提取物的乙酸乙酯馏分具有很强的 TYR 抑制活性,IC50 为 18.85 μg/mL。乙酸乙酯馏分的 TLC 图谱显示,标准品的 Rf 值为 0.28,提取物的 Rf 值为 0.26、0.21 和 0.15,馏分的 Rf 值为 0.26 和 0.15。Asiaticoside 通过阐明细胞因子、生长因子、细胞外基质和黑色素降解酶,抑制了涉及角质细胞、黑色素细胞、成纤维细胞和内皮细胞的多种分子途径,从而抑制了黑色素的生成:富含积雪草苷的积雪草提取物通过其 TYR 抑制活性和多种分子途径,具有作为抗黑色素生成剂的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of HerbMed Pharmacology
Journal of HerbMed Pharmacology Pharmacology, Toxicology and Pharmaceutics-Drug Discovery
CiteScore
2.50
自引率
0.00%
发文量
49
审稿时长
12 weeks
期刊介绍: Journal of Herbmed Pharmacology (J Herbmed Pharmacol) is the intersection between medicinal plants and pharmacology. This international journal publishes manuscripts in the fields of medicinal plants, pharmacology and therapeutic. This journal aims to reach all relevant national and international medical institutions and persons in electronic version free of charge. J Herbmed Pharmacol has pursued this aim through publishing editorials, original research articles, reviews, mini-reviews, commentaries, letters to the editor, hypothesis, case reports, epidemiology and prevention, news and views. In this journal, particular emphasis is given to research, both experimental and clinical, aimed at protection/prevention of diseases. A further aim of this journal is to emphasize and strengthen the link between herbalists and pharmacologists. In addition, J Herbmed Pharmacol welcomes basic biomedical as well as pharmaceutical scientific research applied to clinical pharmacology. Contributions in any of these formats are invited for editorial consideration following peer review by at least two experts in the field.
期刊最新文献
Epigallocatechin gallate, the primary bioactive component from Camellia sinensis: A review on immunomodulatory effects in autoimmune diseases by balancing the differentiation of Th and Treg cells Rethinking the basic action modes of herbal medicine and pondering classical standardization Exploring the anti-acne potential of Muntingia calabura L leaves against Staphylococcus epidermidis: In vitro and in silico perspective Solanum trilobatum leaf extract-derived silver nanoparticles downregulate the PI3K/AKT/mTOR signaling pathway and attenuate oral squamous cell carcinoma cell proliferation Integrative computational approaches for designing novel alpha-glucosidase inhibitors based on curculigoside A derivatives: Virtual screening, molecular docking, and molecular dynamics
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1